Impaired heart function is the main reason for increased mortality of diabetes mellitus. Development of drugs with cardioprotective effects against diabetic myocardiopathy would benefit patients with diabetes. In this study, we tested the cardioprotective effects of Daming capsule (DMC), a traditional Chinese formula, on heart function in streptozocin (STZ)-induced diabetic rats with high fat-diet (HFD). DMC 100 mg/kg/d markedly decreased fasting blood glucose (FBG) and total cholesterol (TC), but did not affect triglycerides (TG) in diabetic rats at 30 d. The decreased heart rate (HR) and prolonged QT and PR interval induced by diabetes mellitus were significantly reversed by DMC (pϽ0.05). The mechanism may involve that DMC attenuated L-type calcium channel a a 1c subunit increasing and Kv4.2 decreasing at both mRNA and protein level in diabetic rats. Additionally, DMC could obviously ameliorate the impaired heart function of diabetic rats by decreasing elevated left ventricular end-diastolic pressure (LVEDP) and increasing the attenuated maximum change velocity of left ventricular pressure in the isovolumic contraction or relaxation period (؎dp/dt max ). Transmission electron microscopy (TEM) results showed that myocardium injury was attenuated by DMC (100 mg/kg/d) in STZ-induced diabetic rats with HFD. In conclusion, DMC could recover the prolonged QT interval and PR interval and elevated diastolic and systolic function of diabetic heart. This protective effect may partially be mediated through affecting the mRNA and protein expression of Kv4.2 and a a 1c as well as preventing cardiomyocyte morphological remodeling.
Abnormal heart function is a common syndrome in patients with diabetes mellitus (DM) and is becoming a major cause of mortality. 1, 2) Drugs with protective effects on heart function and prevention of myocardial remodeling might decrease mortality associated with DM. Hypoglycemic agents used for the treatment of diabetic patients, such as thiazolidinediones (TDs), usually act primarily by decreasing insulin resistance and regulating lipid metabolism. Although some clinic trails have investigated the relationship between the TDs and the risk of congestive heart failure (CHF), conflicting results have led to limited use of TDs in diabetic patients with coexisting cardiovascular disease. [3] [4] [5] [6] [7] [8] Recently, some studies showed that statin therapy could slow the progression of diabetic nephropathy and potentially exert other renoprotective effects, 9) and one meta-analysis of Ͼ18000 diabetic patients across 14 trials supported that all diabetic patients at "sufficiently high risk" for vascular events could benefit from statins. 10, 11) Nevertheless, long-term treatment with statins could easily induce rhabdomyolysis. Angiotensin II type 1 receptor blocker (ARB) could effectively attenuate myocardial remodeling and preserve diastolic function in diabetic heart. 12) The cardioprotective effects of ARB in diabetic patients were a result of its anti-hypertension action. However, DM itself can cause a specific form of cardiomyopathic state independent of vascular complications, such as hypertension. 13) Therefore it is very important to develop drugs for preserving the impaired heart function induced by DM.
Traditional Chinese medicine formulas have prominent advantages because of their stable curative effects with low toxicity. The principle of traditional Chinese medicine is integrity. Traditional Chinese formulas treat diseases from different aspects at the same time, by aiming to arouse the whole body's potential to recover health. Daming capsule (DMC) was designed and carefully organized in accordance with the rule of the traditional Chinese medical compatibility, jun, chen, zuo, shi (monarch, minister, adjuvant and messenger) after selecting proper herbs and relevant dosage, and mainly comprises Rheum Palmatu, Cassia obtusifolia L., Salvia miltiorrhiza, and Panax ginseng C.A. The idea was that these herbs used together would synergize the desirable effects from different mechanisms and decrease side effects. In the formula, Rheum Palmatu is considered as monarch drug because of its actions on promoting digestion and removing food retention as well as promoting blood circulation to dissipate blood stasis (Pharmacopoeia of the People's Republic of China, 2000) . Worldwide studies have shown that Emodin (a mainly effective element of Rheum Palmatum) has hypolipidemic and anti-cancer action. 14, 15) However its cardiac effects have sparsely been reported. Cassia obtusifolia L. also has hypolipidemic, 16, 17) hypotensive, 18) antihepatotoxic, 19) and antibacterial effects. 20) In this formula, Cassia obtusifolia L. could enhance the pharmacological actions and compensate for the adverse effects of Rheum Palmatu due to its benefiting yin effects (Pharmacopoeia of the People's Republic of China, 2000) . Therefore Cassia obtusifolia L. is named as minister drug in the present formula. Salvia miltiorrhiza is also designed as a minister drug because of its similar function with Cassia obtusifolia L. (Pharmacopoeia of the People's Republic of China, 2000) . In studies of modern medicine, Salvia miltiorrhiz has cardioprotective effects, but research and clinical application mostly focus on myocardial ischemia. [21] [22] [23] [24] Panax ginseng C.A. is a kind of immunomodulatory drug 25, 26) 27, 28) Our previous study showed that DMC is effective in lipidemic modulation and the DMC is currently in phase III trial as a hypolipidemic drug. The present study was designed to investigate whether DMC could preserve impaired heart function in rats with DM. Quality Control by Quantitative Analysis of Total Anthraquinones High-performance liquid chromatography (HPLC) analysis of the total anthraquinones in DMC was performed by marker compound Chrysophanol. Chromatographic separation was carried out with a ZORBAX C18 column (250 mmϫ4.6 mm, 5 mm) with a mobile phase composed of methanol-1% phosphate acid solution (85 : 15), detection wavelength at 254 nm, and flow rate at 1.0 ml/min. The content of Chrysophanol was more than 1.5 mg in each capsule (300 mg) estimated from standard calibration curve using authentic standard and the qualified standard.
MATERIALS AND METHODS

Chemicals and Herbal Materials
Animals Male Wistar rats (the Animal Center of the 2nd Affiliated Hospital of Harbin Medical University, China) were used in this study. Rats were housed in a temperature (23Ϯ1°C) and humidity (55Ϯ5%)-controlled room with 12 h dark/light cycle and allowed food and water unlimited according to the policy of Good Laboratory Practice (GLP). Use of animals was in accordance with the regulations of the ethic committees of Harbin Medical University.
Establishment of Diabetic Model According to our previous studies, 29, 30) Wistar rats (180-220 g) were intragastrically administered with fat emulsion (10 ml/d) for 15 d. Fat emulsion was prepared with 20 g lard, 1 g thyreostat, 5 g cholesterol, 1 g sodium glutamate, 5 g sucrose, 5 g saccharu, 20 ml tween-80, and 30 ml propylene glycol, distilled water was then added to 100 ml. Fat emulsion was kept in a refrigerator at 4°C. DM was induced in the rats by intraperitoneal (i.p.) injection of 40 mg/kg/d streptozocin (STZ) (Sigma Chemicals) in a 0.1 M citrate buffer solution (pH 4.2) for 2 d. Blood samples were collected and fasting blood glucose (FBG) level was measured at 72 h after the last injection of STZ by Grace glucometer (Grace Medical, Inc. America) to ensure induction of DM (glycemia Ն16.7 mm). Forty-eight rats with DM were randomly divided into 4 groups (12 rats/group), as follows: diabetic model (DM); high-dose DMC (200 mg/kg/d); middle-dose DMC (100 mg/kg/d); lowdose DMC (50 mg/kg/d). Six rats in each group were used for RT-PCR analysis; the remaining 6 rats were prepared for TEM test. DMC was intragastrically administered for 30 d. At the same time, all 4 groups were intragastrically administered with fat emulsion (10 ml/d). Ten healthy Wistar rats (200-250 g) were used as the control group (Ctr), they were treated with the same volume of 0.9% NaCl when other rats were treated with STZ and drug.
Biochemical Estimations Blood Samples were collected from tail vein to test FBG after fasting for 12 h. Blood was collected from heart, then separated and analyzed for total cholesterol (TC) and triglycerides (TG) using appropriate kits (Nanjing Jiancheng Bioengineering Institute, China).
In Vivo Electrocardiogram (ECG) Studies Rats were anesthetized with i.p. sodium pentobarbital (40 mg/kg). Pin electrodes were pricked into rats' limbs for the recording of Lead II ECG. QT and RR interval were measured by BL-420 Data Acquisition & Analysis System (Chengdu Tme Technology Co., Ltd., China). QTc, which is used to rectify the influence of heart rate (HR) on QT interval, is equal to QT interval (ms) divided by the square root of RR interval.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Analysis Total RNA was extracted from heart tissue. Potassium channel Kv4.2 and L-type calcium channel a 1C subunit were detected by RT-PCR. Primers used for amplification were as follows: Kv4.2, forward primer: 5Ј-CCGCACGGGGAAGCTTCACT-3Ј; reverse primer: 5Ј-CCTGGGCTAGACCCACATGGA-3Ј. a 1C , forward primer: 5Ј-TCTTCAGCCCAAACAACAGG-3Ј; reverse primer: 5Ј-GAGATGAGGGACACGCTAACC-3Ј. b-Actin, forward primer: 5Ј-AGGCCCCTCTGAACCCTAAG-3Ј; reverse primer: 5Ј-TGCCACAGGATTCCATACCC-3Ј. PCR was performed for 30 cycles. Each cycle consisted of denaturation at 94°C for 30 s, annealing at 52.5°C for 30 s, and extension at 72°C for 30 s. For a 1C , autoextension at 72°C for 7 min was included after completion of the last cycle. The PCR products were size-fractionated by 2.0% agarose gel electrophoresis. The density and area of each band were analyzed by ChemiImager TM 4000 digital system (Alpha Innotech Corp., U.S.A.).
Western Blot Membrane protein samples were extracted from rat hearts for immunoblotting analysis of ion channel proteins, with procedures essentially the same as described in detail elsewhere.
31) The protein content was determined with Sunrise-Basic Tecan (Austria) using bovine serum albumin as the standard.
Membrane protein sample was fractionated by SDS-PAGE (10% polyacrylamide gels) and transferred to PVDF membrane (Bio-Rad, Hercules, CA, U.S.A.). The sample was incubated 3 h and overnight at 4°C with the primary antibodies of Kv4.2 (the pore-forming a-subunit of I to ) and Ca v 1.2 (for the a 1c subunit of I CaL ) in 1 : 200. Affinity purified polyclonal primary antibodies against C-termini of human Ca v 1.2 and Kv4.2 was both raised in goat. Inhibitory peptide for each antibody was used to test the antibody specificity. Next day, the membrane was washed in PBS-T 3 times (10 min each) and incubated for 2.5 h with HRP-conjugated donkey antigoat Ig (1 : 1000) in the blocking buffer. Both primary and secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.), Bound antibodies were detected by Odyssey infrared imaging system (LI-COR, Lincoln, NB, U.S.A.). b-Actin was used as internal control for equal input of protein samples, using anti-b-actin antibody purchased from Santa Cruz (CA, U.S.A.). Coomassie staining was also performed to verify the sample quantity. Western blot bands were quantified using Quantity One software by measuring the band intensity (AreaϫOD) for each group and normalizing to b-actin. The final results are expressed as fold changes by normalizing the data to the control values.
In Vivo Heart Function Studies After ECG was recorded, catheter was inserted into the left ventricle via the right common carotid artery to record cardiac electrophysiologic parameters. HR, left ventricular end-diastolic pressure (LVEDP), and maximum change velocity of left ventricular pressure in the isovolumic contraction or relaxation period (Ϯdp/dt max ) were measured by BL-420 Data Acquisition & Analysis System. Transmission Electron Microscopy (TEM) Analysis Specimens were prepared by routine methods for TEM analysis, 1 mm Epon embedded sections were stained with uranyl acetate and lead citrate and examined by JEOL 1200 electron microscope (JEOL Co., Japan).
Statistical Analysis Data were analyzed by one-way ANOVA. A significant difference was determined when pϽ0.05. Comparison between two groups was done using Student's t-test.
RESULTS
Biochemical Estimations
After rats were treated with STZ as well as high-fat emulsion for 45 d, FBG, TG, and TC were significantly increased as shown in Table 1 . DMC effectively decreased FBG and TC after 30-d treatment. However, the effects were not dose-dependent, because FBG and TC in DMC (50 mg/kg/d) group were not significantly changed compared with the diabetic group and those in DMC (200 mg/kg/d) group were similar with those in the DMC (100 mg/kg/d) group. No significant change of TG was observed in all groups.
In Vivo Cardiac ECG Studies As shown in Table 2 and Fig. 1 , HR was significantly reduced in STZ-induced diabetic rats with HFD compared with control group (Ctr) (pϽ0.01). The decrease in HR in diabetic rats was reversed by DMC administration. Furthermore, the prolonged QT interval and PR interval in diabetic rats were partially recovered by DMC treatment (pϽ0.01).
RT-PCR and Western Blot Analysis
The mRNA level of a 1C slightly increased in diabetic rat heart. However, it was decreased by approximately 16% in the DMC groups compared with the DM group (pϽ0.05) (Fig. 2A) . The level of Kv4.2 decreased in the DM group, but increased by 19.2% in the DMC group compared with diabetic rats (Fig. 2B ). The changes of mRNA level did not directly represent the functional changes; therefore we assessed the protein expression of Ca v 1.2 and Kv4.2 by Western blotting analysis with membrane protein samples extracted from hearts of each group. When normalized to internal control with b-actin for protein sample input, the density of the Ca v 1.2 band was decreased by 23% in DMC rats compared with DM rats, but was still increased by 11% compared with Ctr rats. The same method was performed to evaluate protein expression of Kv4.2. The density of the Kv4.2 band was increased by 22% in DMC rats compared with diabetic rats (Fig. 2D) .
In Vivo Heart Function Studies The decreased ϩdp/dt max in diabetic rats induced by STZ with HFD was elevated by 30 d DMC treatment (384.56Ϯ59.08 kPa/S for Ctr rats, 251.38Ϯ37.23 kPa/S for STZ induced rats, and 294.41Ϯ40.68 kPa/S for DMC rats) (Fig. 3A) . So as to remove the effects of pre-load and after-load of heart on the ϩdp/dt max , we further calculated the Log value of ϩdp/dt max . The results implied the same trend as with ϩdp/dt max (Fig.  3B) . Remarkably, LVEDP was notably increased in diabetic rats (0.49Ϯ0.04) compared with control rats (Ϫ0.5Ϯ0.06, pϽ0.05, nϭ6). LVEDP in rats with DMC treatment was decreased (Ϫ0.35Ϯ0.12) compared with diabetic rats (Fig.  3D) . Ϫdp/dt max is another index to evaluate diastolic func- tion. In the experiment, diastolic function was markedly impaired in diabetic rats (Ϫ225Ϯ83.54 kPa/S) compared with Ctr rats (Ϫ343.46Ϯ83.54 kPa/S). DMC (100 mg/kg/d) could effectively recover this parameter to Ϫ266Ϯ29.01 kPa/S (Fig. 3C) . TEM Analysis Compared with control rats, samples from the left ventricle of the diabetic rats showed disordered sarcomere, swollen mitochondria, slightly expanded sarcoplasmic reticulum, and lipid droplet. Cardiomyocyte nucleus also had morphological changes in diabetic rat hearts, including gravel-like nuclei and thickened nuclear membrane. Cellular organelles around the nucleus and among myofilament were reduced. Samples from DMC rat showed widened interspace between myofilament, thickened nuclear membrane, and accumulated heterochromatin. However, compared with samples from DM, integrity of sarcomere was better and swelling of mitochondria was slighter (Fig. 4) .
DISCUSSION
We successfully established an animal model of DM with hyperlipemia using STZ treated Wistar rats with HFD. Our results showed that DMC could not only decrease elevated TC level but also effectively decrease FBG in diabetic rats, although FBG level was still higher than in control animals, which was in accordance with the results of clinical trial. However, the hypoglycemic action of DMC was not dose dependent. The hypoglycemic action of DMC at a dosage of 100 mg/kg/d was higher than that with 50 mg/kg/d, but similar with 200 mg/kg/d. This result may be due to the characteristics of herbal medicines. Low-dosage DMC (50 mg/kg/d) may contain insufficient Rheum Palmatu and therefore we could not observe enough drug action. However, the toxicity of Rheum Palmatu at highest dose of DMC (200 mg/kg/d) was increased, and not counter-balanced by accompanying elevated minister drugs, e.g. Cassia obtusifolia L. and Salvia miltiorrhiza. Hence DMC 200 mg/kg/d could not exert its hypoglycemic action due to decreased defense function of the body induced by Rheum Palmatu. Our result suggests that the optimal dose of DMC is 100 mg/kg/d. Therefore we selected the dosage of 100 mg/kg/d to study the effects of DMC on cardiac function of diabetic rats. We did not select any marketed drug as control drug because there is no acknowledged and specific drug indicated for diabetic myocardiopathy.
Abnormal prolongation of QT interval is considered the most prominent electrical remodeling in diabetic heart. 33) In our experiment, DMC significantly reduced prolonged QT interval in diabetic rats. Furthermore, PR interval, an index of AV nodal conduction, was also prolonged in the heart of DM rats and shortened by DMC treatment. These results imply that the decreased heart rate in diabetic rats is not only derived by prolonged QT interval but also due to the prolonged PR interval. DMC could ameliorate decreased heart rate in diabetic rats by recovering abnormally prolonged QT interval and PR interval.
Calcium and potassium currents, especially transient outward K ϩ current (I to ), are two very important elements for QT interval in rats. We therefore carried out RT-PCR analysis to explore whether the recovered QT intervals by DMC treatment discovered in our experiments were associated with changed inward L-type calcium current and outward Ito currents. Kv4.2 is a protein of I to and a 1c is of L-type calcium channel. In this study, we found that mRNA expression of Kv4.2 was decreased, and a 1c increased in diabetic rat heart following high fat administration. DMC attenuated the expression of a 1c increasing and Kv4.2 decreasing in STZ-induced diabetic rats. As we know, the function of ion channels is actually conducted by its protein. The results of Western blotting analysis showed that DMC could also attenuate protein expression of Ca v 1.2 increasing and Kv4.2 decreasing in STZ-induced diabetic rats, suggesting that an effect of DMC on both protein and gene expression of L-type calcium channel and transient outward K ϩ channel is possibly responsible for its effects on ECG.
Impaired heart function of diabetic patients, especially diastolic dysfunction, independent of vascular and other diseases even in patients with excellent glucose control by insulin suggests primary myocardial defect in DM. 34, 35) Our data showed that both LVEDP and Ϯdp/dt max of diabetic rats following HFD decreased compared with control group. DMC treatment retrieved cardiac dysfunction in diabetic rats. The results indicate that there are other mechanisms involved in the cadioprotective effect of DMC on diabetic rats.
Diastolic and systolic function of the heart is mainly determined by the morphology and structure of cardiomyocytes. Our study suggests that myocardial ultrastructures were severely damaged in diabetic rats. However, DMC partially prevented the impairment. In conclusion, the protective effects of DMC on impaired heart function in diabetic rats could be due to two effects. First, the effect of DMC on expression of Kv4.2 and a 1c subunit may recover prolonged QT interval and PR interval induced by diabetes; second, DMC elevated diastolic and systolic function of the heart by improving morphological remodeling of cardiomyocytes in DM rats.
In the present study, we could not identify which of these protective effects of DMC in heart are driven by what ingredient in the formula. In future, we will investigate the effects of individual ingredients in the formula on the heart. We also aim to uncover whether DMC could exert protective action on the impaired heart function by improving remodeled vascular function.
